---
title: "Bloomage Biotechnology Corporation Limited (688363.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688363.SH.md"
symbol: "688363.SH"
name: "Bloomage Biotechnology Corporation Limited"
industry: "Personal Care Products"
datetime: "2026-05-19T23:09:12.213Z"
locales:
  - [en](https://longbridge.com/en/quote/688363.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688363.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688363.SH.md)
---

# Bloomage Biotechnology Corporation Limited (688363.SH)

## Company Overview

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is based in Jinan, China.

| Item | Detail |
|------|--------|
| Industry | Personal Care Products |
| Exchange | CN Market |
| Website | [www.bloomagebiotech.com](https://www.bloomagebiotech.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: C (0.45)**

**Industry**: Personal Care Products

| Metric | Value |
|--------|-------|
| Industry Ranking | 17 / 28 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -22.36% |  |
| Net Profit YoY | 677.04% |  |
| P/B Ratio | 2.67 |  |
| Dividend Ratio | 0.28% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 19036995196.12 |  |
| Revenue | 3946796892.41 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 3.63% | C |
| Profit Margin | 6.45% | B |
| Gross Margin | 67.84% | A |
| Revenue YoY | -22.36% | E |
| Net Profit YoY | 677.04% | A |
| Total Assets YoY | 2.49% | C |
| Net Assets YoY | 2.90% | C |
| Cash Flow Margin | 306.64% | A |
| OCF YoY | -22.36% | E |
| Turnover | 0.46 | C |
| Gearing Ratio | 18.18% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Bloomage Biotechnology Corporation Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-22.36%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "677.04%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.67",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.28%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "19036995196.12",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "3946796892.41",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "3.63%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "6.45%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "67.84%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-22.36%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "677.04%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "2.49%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "2.90%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "306.64%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-22.36%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.46",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "18.18%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 75.67 | 19/28 | 750.72 | 376.78 | 326.09 |
| PB | 2.70 | 15/28 | 3.74 | 3.45 | 2.99 |
| PS (TTM) | 4.88 | 23/28 | 5.32 | 4.91 | 4.67 |
| Dividend Yield | 0.27% | 17/28 | 0.70% | 0.24% | 0.21% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Proya (603605.SH) | A | D | A | B | C | B |
| 02 | BYHEALTH (300146.SZ) | B | C | C | A | C | B |
| 03 | FLYCO (603868.SH) | A | D | A | A | C | B |
| 04 | BTN (300957.SZ) | B | C | B | B | C | B |
| 05 | Shanghai Jahwa (600315.SH) | C | B | B | B | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-17T16:00:00.000Z

Total Analysts: **9**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 4 | 44% |
| Hold | 2 | 22% |
| Sell | 3 | 33% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 40.03 |
| Highest Target | 65.00 |
| Lowest Target | 28.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688363.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688363.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688363.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/688363.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**